Literature DB >> 25400183

Chronic thromboembolic pulmonary hypertension complicated with homocystinuria.

Shinpei Ogawa1, Tetsuji Katayama, Koichi Kaikita, Masayo Tsukamoto, Eiichiro Yamamoto, Megumi Yamamuro, Tomoko Tanaka, Kenichi Tsujita, Sunao Kojima, Shinji Tayama, Seiji Hokimoto, Hiroshige Yamabe, Yasuhiro Indo, Fumio Endo, Hiromi Matsubara, Hisao Ogawa.   

Abstract

A 17-year-old boy with homocystinuria was found to have a systolic murmur during a routine examination. Echocardiography demonstrated pulmonary hypertension (PH), and computer tomography angiography showed pulmonary thrombi. Although 12-month anticoagulation treatment reduced the thrombotic material within the main branch, it failed to clear thrombotic materials in the left and right lobar branches. Two years later, the patient was admitted to our hospital due to a worsening of PH. Treatment with bosentan, sildenafil and beraprost, in addition to anti-coagulant therapy, did not improve his PH. Balloon pulmonary angioplasty (BPA) was performed to remove the pulmonary thrombi. BPA markedly improved the patient's hemodynamics and exercise capacity. Close follow-up is scheduled to prevent any potential future thrombotic complications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25400183     DOI: 10.2169/internalmedicine.53.2206

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Hyperhomocysteinemia-related lung disease and hemolytic anemia with bone marrow features masquerading as myelodysplasia.

Authors:  Masayoshi Yamanishi; Atsushi Tamura; Takashi Miyoshi; Shinsaku Imashuku
Journal:  Am J Blood Res       Date:  2021-06-15

2.  A Case of Homocystinuria Misdiagnosed as Moyamoya Disease: A Case Report.

Authors:  Meltem Erol; Ozlem Bostan Gayret; Ozgul Yigit; Kubra Serefoglu Cabuk; Mehmet Toksoz; Mahir Tiras
Journal:  Iran Red Crescent Med J       Date:  2016-03-09       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.